Abstract:Cocrystals easily undergo solution-mediated phase transformation at the surface of dissolving cocrystals during dissolution, which significantly deteriorates the solubility advantage of cocrystals. Here, a new scenario for the phase transformation of liquiritigenin (LQ) cocrystals in which the boundary of phase transformation diffuses along the surface to the bulk of the cocrystal was identified. Additionally, depending on the rate of supersaturation generation, phase transformation processes to the anhydrate and hydrate of LQ compete during cocrystal dissolution. The liquiritigenin − nicotinamide (LQ − NIC) cocrystal yielded a higher supersaturation rate, causing the nucleation kinetics to dominate the recrystallization process and the formation of a metastable form of LQ. However, in the liquiritigenin − isoniazid (LQ − INZ) cocrystal, the low supersaturation rate leading to recrystallization was controlled by thermodynamics and the subsequent formation of monohydrates of LQ (less soluble). As a result, in plain buffer, a multistep pathway for phase transformation of the LQ − NIC cocrystal was observed, in which the cocrystal was first converted into the anhydrate LQ (metastable form) and subsequently transformed into LQ·H2O. A one-step phase transformation was observed for the LQ − INZ cocrystal, where the cocrystal was directly converted to LQ·H2O. In a buffer containing the Eudragit E100 additive, for the LQ − NIC cocrystal, the dissolution performance improved, which can presumably be attributed to the solubilization effect of E100 on the anhydrate and the inhibitory effect on the transformation of the anhydrate to the monohydrate. However, for the LQ − INZ cocrystal, a negligible improvement in drug concentration was observed in the presence of E100 because of the slight effects of E100 on the solubility of LQ·H2O. These findings provide valuable insights into the phase transformation pathways of cocrystals at the liquid–solid interface and the effects of additives on the dissolution behavior of cocrystals.

Mechanistic Study on Complexation-Induced Spring and Hover Dissolution Behavior of Ibuprofen-Nicotinamide Cocrystal

The Binary System of Ibuprofen-Nicotinamide Under Nanoscale Confinement: From Cocrystal to Coamorphous State

Dissolution Behavior of the Crystalline Inclusion Complex Formed by the Drug Diflunisal and Poly(epsilon caprolactone)

Dissolution Behavior of the Crystalline Inclusion Complex Formed by the Drug Diflunisal and Poly(ε-caprolactone)

Bioavailability-Enhancing Cocrystals: Screening, In Vivo Predictive Dissolution, and Supersaturation Maintenance

Mechanistic Analysis of Cocrystal Dissolution as a Function of pH and Micellar Solubilization

Combination of co-crystal and nanocrystal techniques to improve the solubility and dissolution rate of poorly soluble drugs

Increasing the Dissolution Rate of A Low-Solubility Drug Through A Crystalline-Amorphous Transition: A Case Study with Indomethicin

Solution-mediated Phase Transformation of Cocrystals at the Solid–liquid Interface: Relationships Between the Supersaturation Generation Rate and Transformation Pathway

Pharmaceutical Cocrystals: A Novel Systematic Approach for the Administration of Existing Drugs in New Crystalline Form

PREPARATION AND CHARACTERIZATION OF IBUPROFEN COCRYSTALS BY USING SOLVENT DROP GRINDING METHOD

Crystallization Kinetics and Molecular Dynamics of Binary Coamorphous Systems of Nimesulide and Profen Analogs

Impact of Bile Salt on Solution-Mediated Phase Transformation of Pharmaceutical Cocrystals: the Importance of Coformer Release Kinetics

Mechanistic Study on Transformation of Coamorphous Baicalein-Nicotinamide to Its Cocrystal Form

A novel solubilization technique for poorly soluble drugs through the integration of nanocrystal and cocrystal technologies

Influence of Intermolecular Interactions on Crystallite Size in Crystalline Solid Dispersions

Optimisation of Pharmaceutical Cocrystal Dissolution Performance through a Synergistic Precipitation Inhibition

Synergetic effect of nucleation and crystal growth inhibitor on in vitro-in vivo performance of supersaturable lacidipine solid dispersion

Cocrystal Solubility Advantage and Dose/Solubility Ratio Diagrams: A Mechanistic Approach To Selecting Additives and Controlling Dissolution-Supersaturation-Precipitation Behavior

Preparation of quercetin-nicotinamide cocrystals and their evaluation underin vivoandin vitroconditions

Metastable Racemic Ibuprofen Supercooled Liquid